PharmaSGP Is Said to Plan Germany’s Biggest IPO This Year

(Bloomberg) -- PharmaSGP GmbH, which develops chemical-free over-the-counter drugs, is planning an initial public offering that could value the company at as much as 500 million euros ($549 million...